WO2005030233A1 - 活性酸素消去剤及びその製造方法 - Google Patents
活性酸素消去剤及びその製造方法 Download PDFInfo
- Publication number
- WO2005030233A1 WO2005030233A1 PCT/JP2004/012951 JP2004012951W WO2005030233A1 WO 2005030233 A1 WO2005030233 A1 WO 2005030233A1 JP 2004012951 W JP2004012951 W JP 2004012951W WO 2005030233 A1 WO2005030233 A1 WO 2005030233A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- active oxygen
- anthocyanin
- acerola
- decomposition
- oxygen scavenger
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
- C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
Definitions
- the present invention relates to an active oxygen scavenger containing an anthocyanin-based pigment decomposition product and a method for producing the same.
- Active oxygen is oxygen in a highly reactive energy state, specifically, OH-
- phagocytic cells such as neutrophils, monocytes, and macrophages migrate to the local area and start phagocytosis on the invading bacteria and viruses.
- phagocytic cells such as neutrophils, monocytes, and macrophages migrate to the local area and start phagocytosis on the invading bacteria and viruses.
- Patent Document 1 a water-soluble antioxidant derived from safflower leaves and Z or stem is selected from Patent Document 2, and plum is selected from plum, Seiyounatsuyuki, Bengal Karatachi, Miracle Berry, Yaba Santa, and Lemongrass.
- Patent Document 3 discloses an active oxygen scavenger and an iridescent cosmetic composition containing one or more plant extracts, and Patent Document 3 discloses an active oxygen scavenger containing an extract of cotton and Z or yellow flower water lily as an active ingredient. It has been disclosed.
- anthocyanin pigments are pigments abundant in plants and the like, and It is used as a coloring agent by utilizing the color tone.
- anthocyanin dyes are known to have active oxygen scavenging activity, and are widely used in health foods and beverages such as supplements.
- Anthocyanin dyes are generally unstable dyes. Under alkaline conditions, the C ring opens and is decomposed, resulting in fading. It is also easily decomposed and discolored by the influence of temperature, light, etc., but is relatively stable under acidic conditions.
- Acerola a tropical fruit of the genus Hiraguratrano, is a plant rich in anthocyanin pigments. Since the acerola fruit is acidic, the anthocyanin pigment should be stable unless light or heat is applied. In addition, acerola contains a very large amount of vitamin C per 100 g of fruit, in addition to the anthocyanin pigment, which is about 1,500 mg per 100 g of fruit.As a result, the anthocyanin pigment is easily decomposed without applying light or heat. And fade. It is also known that a small amount of iron contained in acerola promotes further decomposition.
- Degradation of anthocyanin pigments caused by vitamins C and Z or metals that occur in acerola's discoloration is a mechanism with a different mechanism than that of 'degradation by PH, temperature, light, etc.' It is also known whether the active oxygen scavenging activity of the dye is maintained after decomposition and fading.
- Patent Document 1 JP-A-2002-38151
- Patent Document 2 JP 2003-183120
- Patent Document 3 Japanese Patent Application Laid-Open No. 2003-246747
- An object of the present invention is to provide an active oxygen scavenger and a method for producing the same.
- An object of the present invention is to provide an active oxygen scavenger containing an anthocyanin-based pigment decomposed product derived from acerola, and a method for producing the same.
- the present inventors have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that It has been found that the decomposed product of tosyanine dyes has active oxygen scavenging activity.
- the present inventors have also found that a decomposition product obtained by decomposing an anthocyanin-based pigment with vitamins C and Z or a metal has an active oxygen elimination activity.
- the present inventors have further found that the active oxygen scavenging activity increases as the decomposition of these decomposition products progresses.
- anthocyanin-based dye a method has been hitherto known in which an alkyl peroxyl radical is reacted with an anthocyanin-based dye, whereby the anthocyanin-based dye is decomposed to generate protocatechuic acid ( Lipids, Vol. 31, No. 12 (1996), ppl259-1263) 0
- Protocatechuic acid is a strong active oxygen scavenger, and therefore, when anthocyanin dyes are decomposed by such a method, the decomposition products are also strong. Active oxygen scavenging It is expected to retain activity.
- vitamin C and Z or a metal is allowed to act on the anthocyanin pigments.
- the analysis showed that protocatechuic acid was produced and that it was obvious. From this, it is clear that the mechanism of anthocyanin-based pigment decomposition is different between the above-mentioned known literature and the present invention. Furthermore, it has not been found that the active oxygen scavenging activity increases as the decomposition of anthocyanin-based pigment degradation products proceeds.
- the present invention includes the following inventions.
- An active oxygen scavenger containing an anthocyanin-based pigment decomposition product derived from acerola as an active ingredient is an active oxygen scavenger containing an anthocyanin-based pigment decomposition product derived from acerola as an active ingredient.
- a method for producing an active oxygen scavenger comprising decomposing an anthocyanin-based pigment derived from acerola.
- An active oxygen scavenger containing, as an active ingredient, a treated product obtained by treating fruit juice derived from acerola or an extract or treated product thereof at 30 ° C. to 90 ° C.
- An active oxygen scavenger containing an anthocyanin-based pigment decomposition product obtained by decomposing an anthocyanin-based pigment with vitamins C and Z or a metal obtained by decomposing an anthocyanin-based pigment with vitamins C and Z or a metal.
- An active acid including decomposing anthocyanin pigments with vitamins C and Z or a metal A method for producing an element-erasing agent.
- the active oxygen scavenger of the present invention contains an anthocyanin-based pigment decomposition product having active oxygen scavenging activity, and is effective for preventing and treating various diseases and aging related to active oxygen. .
- the present invention also provides a use of an anthocyanin-based pigment decomposition product which has not been used conventionally.
- the active oxygen scavenger derived from acerola provided in the present invention is derived from a natural component, and thus has little problem of side effects.
- FIG. 1 is a view showing a change over time in the active oxygen scavenging activity of an anthocyanin-based pigment decomposition product generated by fading of acerola juice.
- Fig. 2 is a graph showing the time-dependent change in the active oxygen scavenging activity of an anthocyanin-based pigment decomposition product produced when acerola-based purified anthocyanin-based pigment is faded in the presence of vitamin C and iron. is there.
- Fig. 3 is a graph showing the time course of the DPPH radical scavenging activity of an anthocyanin-based pigment degradation product generated when a standard siadin chloride is faded in the presence of vitamin C and iron. is there.
- the present invention relates to an active oxygen scavenger containing an anthocyanin-based pigment decomposition product derived from acerola and a method for producing the same.
- acerola juice obtained by squeezing acerola fruit is Although it can be used as it is, it may be used after pulverizing the fruit by crushing, pulverizing, or the like, or may be used as an extract or processed product thereof.
- the organic solvent used for the extraction is preferably a hydrophilic organic solvent.
- the hydrophilic organic solvent include alcohols such as methyl alcohol, ethyl alcohol, glycerin, propylene glycol, and 1,3-butylene glycol, cetone, tetrahydrofuran, acetonitrile, 1,4-dioxane, pyridine, dimethyl sulfoxide, and the like.
- Known organic solvents such as ⁇ , ⁇ -dimethylformamide, acetic acid and the like can be mentioned.
- the above hydrophilic organic solvents, particularly methyl alcohol and ethyl alcohol are preferably used as a mixture with water.
- the extraction conditions are not particularly limited, but a preferred temperature range is 5 ° C to 90 ° C, particularly 20 ° C to 40 ° C.
- the extraction time is preferably about 1 hour to 10 hours, particularly about 1 hour to 12 hours.
- the amount of the solvent used for the extraction is preferably 1 to 20 times the mass of the raw material.
- the extraction residue is removed by filtration or centrifugation to obtain an extract.
- This extract can be concentrated if necessary.
- the acerola juice thus obtained or its extract or processed product contains an anthocyanin pigment, vitamin C and iron, and can be obtained without adding vitamin C and Z or a metal.
- the anthocyanin pigments can be decomposed by vitamin C and Z or iron to decompose.
- acerola juice or its extract or processed product may be supplemented with vitamins C and Z or a metal.
- Decomposition conditions are not limited, but for example, a decomposition temperature of 30 ° C to 90 ° C is preferable.
- the decomposition time can be changed as appropriate depending on the decomposition temperature.For example, if the decomposition temperature is as low as 30 ° C, it is about 10 to 50 days, and if the decomposition temperature is as high as 90 ° C, it is about 1 to 15 hours. Is preferred.
- Particularly preferred decomposition conditions are 10 days to 50 days at a low temperature of 30 ° C. to 50 ° C.
- anthocyanin-based dyes include sia-zine, manolevidin, delphi-zine, petunidin, zeo-dine, pelarg- ozine, and glycosides using these as aglycones, and in particular, sia-zine. ! /, That glycoside is preferred! / ,.
- vitamin C commonly available vitamin C may be used.
- the metal used for the decomposition is not particularly limited as long as it promotes the decomposition of the anthocyanin dye, and examples thereof include metal salts such as iron and copper, and iron is particularly preferable. .
- the amount of added vitamin C of vitamin C is preferably 5 to 100 times, particularly preferably 50 to 100 times the amount of the anthocyanin pigment.
- the amount of metal added is preferably in the range of 1/10 to 1/2, particularly preferably in the range of 1/10 to 1/4 of that of the anthocyanin pigment.
- the conditions for the decomposition are not particularly limited, but the decomposition can be performed in the same manner as the decomposition of the anthocyanin-based pigment derived from acerola described above.
- the anthocyanin-based pigment decomposition product of the present invention can be used as an active oxygen scavenger as a mixture with vitamin C and a metal, but after the production, a purification step for removing remaining vitamin C, a metal and the like is performed. You may.
- the purification method include normal-phase or reverse-phase chromatography, ion-exchange chromatography, and gel filtration. In particular, use of reverse-phase chromatography is preferred. Also, these methods can be used in combination.
- the active oxygen scavenger of the present invention can be formulated by combining acerola juice, an extract or purified product, or an anthocyan-based pigment decomposition product with a known pharmaceutical carrier.
- the administration form is not particularly limited and may be appropriately selected as necessary. In general, tablets, capsules, granules, fine granules, powders, liquids, syrups, suspensions, emulsions, elixirs, etc. Or oral, or parenteral preparations such as injections, drops, suppositories, inhalants, transdermal absorbents, transmucosal absorbents, patches and ointments.
- the addition amount of the active oxygen scavenger of the present invention varies depending on conditions such as the type of the object to be added, the use form, and the like. preferable.
- the dosage of the active oxygen scavenger of the present invention varies depending on the age, weight, degree of disease, and administration route of the patient, but for oral administration, usually 10 mg / day as dry powder of acerola extract. It is 3000 mg, and the frequency of administration is usually one to three times a day for oral administration.
- Oral preparations are produced by an ordinary method using excipients such as starch, lactose, sucrose, mannitol, carboxymethylcellulose, corn starch, inorganic salts and the like.
- a binder In this type of preparation, a binder, a disintegrant, a surfactant, a lubricant, a fluidity promoter, a flavoring agent, a coloring agent, a fragrance, and the like may be used in addition to the excipients as appropriate.
- a binder a disintegrant, a surfactant, a lubricant, a fluidity promoter, a flavoring agent, a coloring agent, a fragrance, and the like may be used in addition to the excipients as appropriate.
- a disintegrant e.g., a surfactant, e.g., a surfactant, a lubricant, a fluidity promoter, a flavoring agent, a coloring agent, a fragrance, and the like may be used in addition to the excipients as appropriate.
- a disintegrant e.g., a surfactant, e.g., a lubricant, e.g., a
- binder examples include crystalline cellulose, crystalline cellulose 'carmellose sodium, methylcellulose, hydroxypropylcellulose, low-substituted hydroxypropylcellulose, hydroxypropinolemethinoresenorelose, and hydroxypropinolemethinoresenorelose.
- disintegrants include crystalline cellulose, methylcellulose, low-substituted hydroxypropinoresenololeose, canolemelose, canolemelose kanoresum, canolemelose sodium, croscarmellose sodium, wheat starch, rice starch , Corn starch, potato starch, partially alpha starch, hydroxypropyl starch, sodium carboxymethyl starch and tragacanth.
- surfactant examples include soybean lecithin, sucrose fatty acid ester, polyoxyl stearate, hydrogenated castor oil of polyoxyethylene, polyoxyethylene polyoxypropylene glycol, sorbitan sesquioleate, sorbitan trioleate, and monoester. Sorbitan stearate, sorbitan monopalmitate, sorbitan monolaurate, polysorbate, Glycerin monostearate, sodium lauryl sulfate and lauromacrogol are mentioned.
- lubricant examples include wheat starch, rice starch, corn starch, stearic acid, calcium stearate, magnesium stearate, hydrated silicon dioxide, light silicic anhydride, synthetic aluminum silicate, and dried hydroxy acid.
- examples include dani aluminum gel, talc, magnesium aluminate metasilicate, calcium hydrogen phosphate, anhydrous calcium hydrogen phosphate, sucrose fatty acid esters, waxes, hydrogenated vegetable oils, and polyethylene glycol.
- fluidity promoter examples include hydrous silicon dioxide, light caustic anhydride, dry aluminum hydroxide gel, synthetic aluminum silicate, and magnesium silicate.
- the active oxygen scavenger of the present invention may contain a flavoring agent and a coloring agent.
- the active oxygen scavenger of the present invention is also used in accordance with ordinary methods for skin care cosmetics such as lotions, emulsions, creams, packs, and cleaning agents, makeup cosmetics such as lipsticks and foundations, and hair cosmetics. Can be added.
- the active oxygen scavenger of the present invention can be further added to foods, candy, troches, jams, gums, beverages and the like according to a conventional method.
- the active oxygen scavenger of the present invention can be used as it is as an extract dry powder. Further, it may be a so-called food for specified health use (for example, a food for preventing arteriosclerosis).
- Metals such as acerola, anthocyanin pigments, vitamin C and iron used in the production of the active oxygen scavenger of the present invention have been used in cosmetics, foods and the like to date, and their safety has been established. I have.
- Acerola was squeezed with gauze, and the juice obtained after centrifugal filtration was treated with vectorinase for 2 hours to eliminate viscosity.
- the obtained solution was sterilized with a filter, and then aseptically incubated at 40 ° C. for about one month.
- the red color of the acerola juice gradually faded, and after 5 days completely faded.
- the bleached juice is applied to a C18 cartridge column (BAKERBOND spe (registered trademark) C18 disposable monkey column), and washed thoroughly with distilled water.
- the column adsorbed fraction was eluted with 0.2% TFA / methanol solution.
- the obtained eluate was concentrated using an evaporator, and then redissolved in the same amount of distilled water as the bleached juice applied to the column.
- the active oxygen scavenging activity was evaluated for the sample obtained by the above-described operation, and the sample obtained by diluting the sample two and four times.
- the reactive oxygen scavenging activity was evaluated by the scavenging activity of superoxide-one radical by xanthine-xanthine oxidase reaction system, and ESR was used for detection of radical.
- DMPO (5,5-dimethyl-l-pyrroline-N-oxide) 15 ⁇ 1, 50 mM phosphate buffer ( ⁇ 7.4) 50 ⁇ 1, sample 501, 2 mM hypoxanthine / phosphate buffer solution 501, 0.4 unit / ml xanthine oxidase (XOD) I phosphate buffer 501 was mixed, and ESR measurement was performed 45 seconds after the addition of XOD.
- the ESR device was JES ESR (JES-FR30), and the spectrum analysis by ESR was performed under the following conditions:
- Magnetic field sweep width 335.9 ⁇ 5mT
- magnetic field modulation 0.1mT
- amplification factor 100
- sweep time 2 minutes response time
- FIG. 1 shows the measurement results.
- FIG. 1 shows that the active oxygen scavenging activity tended to increase as the decomposition of the juice progressed.
- Example 1 From Example 1, the power of the acerola juice, in which the active oxygen elimination activity tended to increase as the decomposition progressed, was observed.In this system, the effects of components other than the anthocyanin dye can be considered, so that acerolaca also purified the anthocyanin dye. Then, the same experiment was performed in a simple system using a purified dye. [0065] The final concentrations of the anthocyanin pigment, vitamin C, and iron chloride purified from acerola were adjusted to 0.2, 10, and 0.02 mg / ml according to the content of acerola fruit in a 0.1 M acetate buffer (pH 3). .0) and incubated at 40 ° C for about 1 month.
- the prepared solution after 0, 7, 14, 21, 28, and 35 days of incubation is applied to a C18 cartridge column, washed thoroughly with distilled water, and the fraction adsorbed on the C18 column is washed with 0.2% TFA / methanol solution. Eluted.
- the obtained eluate was concentrated by an evaporator, and then redissolved in the same amount of distilled water as the prepared solution applied to the column.
- the active oxygen scavenging activity was evaluated for the sample obtained by the above operation and the sample obtained by diluting the sample by 2, 4, 8, and 16 times.
- Example 1 The method for evaluating the active oxygen scavenging activity is the same as in Example 1.
- FIG. 2 shows the measurement results.
- the active oxygen scavenging activity As shown in FIG. 2, as in the case of acerola juice, there was a tendency for the active oxygen scavenging activity to increase as the pigment decomposition progressed.
- This experiment was performed in a simple system, and the components adsorbed on the C18 column were limited to anthocyanin-based pigment decomposition products. In fact, the power of examining the vitamin C content of this adsorbed component Vitamin C was not detected at all. Therefore, it was found that the active oxygen scavenging activity of the anthocyanin-based dye in Acerola increased as the decomposition proceeded.
- a standard siadin chloride was adjusted to a concentration of 0.075mg / ml in a 0.1M acetate buffer (
- Evaluation was performed by the DPPH method. 2.5 ml of 0.1 M phosphate buffer (pH 6.5), 99% ethanol in 0.5 ml of sample Nord 1.0ml, mixed 5 X 10- 4 M DPPH- ethanol solution 1.0ml and allowed to stand at room temperature. The absorbance at 525 nm was measured over time to evaluate the radical scavenging activity.
- the active oxygen scavenger of the present invention is effective for preventing and treating various diseases and aging related to active oxygen.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Virology (AREA)
- Mycology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-336062 | 2003-09-26 | ||
JP2003336062A JP4414711B2 (ja) | 2003-09-26 | 2003-09-26 | 活性酸素消去剤及びその製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005030233A1 true WO2005030233A1 (ja) | 2005-04-07 |
Family
ID=34386086
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/012951 WO2005030233A1 (ja) | 2003-09-26 | 2004-09-06 | 活性酸素消去剤及びその製造方法 |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4414711B2 (ja) |
WO (1) | WO2005030233A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101171266B (zh) * | 2005-02-28 | 2012-05-16 | 株式会社日冷食品 | 来源于西印度樱桃果实的果胶和其应用 |
JP4888363B2 (ja) * | 2007-12-05 | 2012-02-29 | カルピス株式会社 | 飲料の退色防止法 |
JP5574600B2 (ja) * | 2007-12-17 | 2014-08-20 | 日本製薬工業株式会社 | 吸収性骨疾患の予防・治療剤 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH072640A (ja) * | 1992-10-29 | 1995-01-06 | Marino Forum 21 | 紫外線障害防御外用剤 |
JPH09241637A (ja) * | 1996-03-14 | 1997-09-16 | Chugai Pharmaceut Co Ltd | 活性酸素ラジカル除去用組成物およびその方法 |
JP2000176272A (ja) * | 1998-12-16 | 2000-06-27 | House Foods Corp | 造粒物及び錠剤の製造方法 |
JP2001504467A (ja) * | 1996-11-13 | 2001-04-03 | ザ、プロクター、エンド、ギャンブル、カンパニー | 消毒マイクロエマルジョン |
JP2001329186A (ja) * | 2000-05-22 | 2001-11-27 | Tomoko Shimizu | アントシアニン系色素の安定法と生成物 |
JP2002179578A (ja) * | 2000-12-14 | 2002-06-26 | Noevir Co Ltd | 高分子化抗酸化剤、及びこれを含有する皮膚外用剤 |
JP2003508415A (ja) * | 1999-08-27 | 2003-03-04 | ミシガン ステイト ユニヴァーシティー | 天然シクロオキシゲナーゼ阻害剤を含有する食物サプリメント |
JP2003334023A (ja) * | 2002-05-20 | 2003-11-25 | Hiroka Hirosaki Chuo Seika Kk | 生食原料中のポリフェノールの増量方法 |
-
2003
- 2003-09-26 JP JP2003336062A patent/JP4414711B2/ja not_active Expired - Lifetime
-
2004
- 2004-09-06 WO PCT/JP2004/012951 patent/WO2005030233A1/ja active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH072640A (ja) * | 1992-10-29 | 1995-01-06 | Marino Forum 21 | 紫外線障害防御外用剤 |
JPH09241637A (ja) * | 1996-03-14 | 1997-09-16 | Chugai Pharmaceut Co Ltd | 活性酸素ラジカル除去用組成物およびその方法 |
JP2001504467A (ja) * | 1996-11-13 | 2001-04-03 | ザ、プロクター、エンド、ギャンブル、カンパニー | 消毒マイクロエマルジョン |
JP2000176272A (ja) * | 1998-12-16 | 2000-06-27 | House Foods Corp | 造粒物及び錠剤の製造方法 |
JP2003508415A (ja) * | 1999-08-27 | 2003-03-04 | ミシガン ステイト ユニヴァーシティー | 天然シクロオキシゲナーゼ阻害剤を含有する食物サプリメント |
JP2001329186A (ja) * | 2000-05-22 | 2001-11-27 | Tomoko Shimizu | アントシアニン系色素の安定法と生成物 |
JP2002179578A (ja) * | 2000-12-14 | 2002-06-26 | Noevir Co Ltd | 高分子化抗酸化剤、及びこれを含有する皮膚外用剤 |
JP2003334023A (ja) * | 2002-05-20 | 2003-11-25 | Hiroka Hirosaki Chuo Seika Kk | 生食原料中のポリフェノールの増量方法 |
Non-Patent Citations (8)
Title |
---|
FURTADO P. ET AL.: "Photochemical and thermal degradation of anthocyanidins", J. PHOTOCHEM. PHOTOBIOL. A: CHEM., vol. 75, no. 2, 1993, pages 113 - 118, XP002903443 * |
HA J.H. ET AL.: "4-hydroxybenzaldehyde from Gastrodia elata B1. is active in the antioxidation and GABAergic neuromodulation of the rat brain", J. ETHNOPHARMACOLOGY, vol. 73, no. 1-2, pages 329 - 333, XP002903447 * |
MACCARONE E. ET AL.: "Effects of light on anthocyanins. Kinetics and phtodegradation products in acidic aqueous solutions", ANNALI DI CHIMICA, vol. 77, no. 5, 1987, pages 499 - 508, XP002903441 * |
MARTI N. ET AL.: "Influence of storage temperature and ascorbic acid addition on pomegranate juice", J. THE SCIENCE OF FOOD AND AGRICULTURE, vol. 82, no. 2, 2002, pages 217 - 221, XP002903444 * |
NAKAMURA Y. ET AL.: "Dihydrochalcones: evaluation as novel radical scavenging antioxidants", J. AGRIC. FOOD CHEMISTRY, vol. 51, no. 11, 21 May 2003 (2003-05-21), pages 3309 - 3312, XP002903446 * |
PIFFAUT B. ET AL.: "Comparative degradation pathway of malvin 3, 5-diglucoside after enzymatic and thermal treatments", FOOD CHEMISTRY, vol. 50, no. 2, 1994, pages 115 - 120, XP002903442 * |
SOGAWA S. ET AL.: "Protective effects of hydroxychalcones on free radical-induced cell damage", BIOL. PHARM. BULL., vol. 17, no. 2, 1994, pages 251 - 256, XP008014988 * |
TSUDA T. ET AL.: "Oxidation products of cyanidin 3-O-beta-D-glucoside a free radival initiator", LIPIDS, vol. 31, no. 12, 1996, pages 1259 - 1263, XP002903445 * |
Also Published As
Publication number | Publication date |
---|---|
JP4414711B2 (ja) | 2010-02-10 |
JP2005104841A (ja) | 2005-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7049496B2 (ja) | 黄ぐすみ低減用皮膚外用剤 | |
US20110207697A1 (en) | Xanthohumol compositions and methods for treating skin diseases or disorders | |
EP1382329A1 (de) | Lichtschutzmittel enthaltend ein Flavonoid | |
KR101973639B1 (ko) | 콩잎 추출물을 함유하는 항산화용 조성물 | |
KR102161179B1 (ko) | 홍차줄기 추출물을 함유하는 항산화성 조성물 | |
KR101793208B1 (ko) | 홍자단 추출물을 포함하는 항산화 또는 항염증 조성물 | |
WO2006068212A1 (ja) | リパーゼ阻害剤及び皮膚疾患の予防・治療剤 | |
JP2004175856A (ja) | 抗酸化剤、コラゲナーゼ活性阻害剤、ヒアルロニダーゼ活性阻害剤、皮膚外用剤、化粧料及び食料品 | |
JP2003081744A (ja) | 抗酸化剤 | |
JP6678928B2 (ja) | 経口美容剤 | |
JP3977889B2 (ja) | 蕎麦殻抽出物を有効成分とする薬剤 | |
WO2005030233A1 (ja) | 活性酸素消去剤及びその製造方法 | |
JP4499371B2 (ja) | 落花生由来のプロアントシアニジンの製造方法 | |
KR101768280B1 (ko) | 카르피너스 푸베센스 추출물을 포함하는 항산화 또는 항염증 조성물 | |
JPH1072358A (ja) | 植物抽出物 | |
JP5462491B2 (ja) | プロアントシアニジン三量体 | |
JP5138330B2 (ja) | マコモタケの発酵処理物 | |
JPH0820544A (ja) | 活性酸素消去剤ならびにこれを配合した食品および化粧料 | |
WO2012004875A1 (ja) | ラン科植物から分離した新規物質、これを含む抽出物、抗酸化剤、抗菌剤、抗癌剤及び抗炎症剤 | |
KR101940055B1 (ko) | 콩잎 추출물을 함유하는 보습용 조성물 | |
KR20170045770A (ko) | 오스만투스 마츠무라누스 추출물을 포함하는 항산화 또는 항염증 조성물 | |
JP2009040735A (ja) | メラニン合成抑制剤 | |
JP6744537B2 (ja) | 毛髪の成長を促進させる組成物 | |
JP2017141204A (ja) | NF−κB抑制作用を呈するグランジフロル酸誘導体及びその製造方法 | |
JP4182230B2 (ja) | 新規配糖体、その製造方法及び組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |